Cargando…
Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures
BACKGROUND: There is little research on whether normoresponsive patients who produced poor-quality embryos once verses those who produced poor-quality embryos twice when using a single COH protocol should change to a different controlled ovarian hyperstimulation (COH) protocol. MATERIAL/METHODS: In...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986211/ https://www.ncbi.nlm.nih.gov/pubmed/31953378 http://dx.doi.org/10.12659/MSM.918705 |
_version_ | 1783491938571255808 |
---|---|
author | Shen, Xi Gao, Hongyuan Chen, Qiuju Cai, Renfei Lyu, Qifeng Wang, Yun Wang, Li Kuang, Yanping |
author_facet | Shen, Xi Gao, Hongyuan Chen, Qiuju Cai, Renfei Lyu, Qifeng Wang, Yun Wang, Li Kuang, Yanping |
author_sort | Shen, Xi |
collection | PubMed |
description | BACKGROUND: There is little research on whether normoresponsive patients who produced poor-quality embryos once verses those who produced poor-quality embryos twice when using a single COH protocol should change to a different controlled ovarian hyperstimulation (COH) protocol. MATERIAL/METHODS: In this retrospective study, we enrolled 108 patients with 1 PPOS failure who chose to continue receiving the progestin-primed ovarian stimulation (PPOS) protocol (n=61) versus those who decided to switch to the modified ultra-long protocol (n=47). We also enrolled 131 normoresponsive patients with 2 PPOS failures who chose to continue receiving the PPOS protocol (n=60) versus those who decided to switch to the modified ultra-long protocol (n=71) in the third cycle. RESULTS: We found no significant difference in clinical outcomes of patients with 1 PPOS failure who continued using the PPOS protocol verses those who switched to the modified ultra-long protocol in the second cycle, expect for a lower cancelation rate (4.3% vs. 16.4%). However, the patients with 2 PPOS failures had significantly more good-quality embryos (0.9 vs. 0.4), more viable embryos (1.8 vs. 0.9), lower cancelation rates (18.3% vs. 53.3%), and higher pregnancy rates per aspirated cycle (26.8% vs. 10.0%) when switching to the modified ultra-long protocol compared to those who decided to continue receiving the PPOS protocol (P<0.05). Furthermore, the odds of clinical pregnancy (odds ratio [OR] 5.997, 95% confidence interval [CI] 1.476–24.361, P=0.01) were positively associated with switching to the COH protocol in the third cycle. CONCLUSIONS: For normoresponsive patients with poor-quality embryos when using the PPOS protocol, switching to the modified ultra-long protocol after having 2 PPOS failures was associated with better ART outcomes. |
format | Online Article Text |
id | pubmed-6986211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69862112020-02-06 Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures Shen, Xi Gao, Hongyuan Chen, Qiuju Cai, Renfei Lyu, Qifeng Wang, Yun Wang, Li Kuang, Yanping Med Sci Monit Clinical Research BACKGROUND: There is little research on whether normoresponsive patients who produced poor-quality embryos once verses those who produced poor-quality embryos twice when using a single COH protocol should change to a different controlled ovarian hyperstimulation (COH) protocol. MATERIAL/METHODS: In this retrospective study, we enrolled 108 patients with 1 PPOS failure who chose to continue receiving the progestin-primed ovarian stimulation (PPOS) protocol (n=61) versus those who decided to switch to the modified ultra-long protocol (n=47). We also enrolled 131 normoresponsive patients with 2 PPOS failures who chose to continue receiving the PPOS protocol (n=60) versus those who decided to switch to the modified ultra-long protocol (n=71) in the third cycle. RESULTS: We found no significant difference in clinical outcomes of patients with 1 PPOS failure who continued using the PPOS protocol verses those who switched to the modified ultra-long protocol in the second cycle, expect for a lower cancelation rate (4.3% vs. 16.4%). However, the patients with 2 PPOS failures had significantly more good-quality embryos (0.9 vs. 0.4), more viable embryos (1.8 vs. 0.9), lower cancelation rates (18.3% vs. 53.3%), and higher pregnancy rates per aspirated cycle (26.8% vs. 10.0%) when switching to the modified ultra-long protocol compared to those who decided to continue receiving the PPOS protocol (P<0.05). Furthermore, the odds of clinical pregnancy (odds ratio [OR] 5.997, 95% confidence interval [CI] 1.476–24.361, P=0.01) were positively associated with switching to the COH protocol in the third cycle. CONCLUSIONS: For normoresponsive patients with poor-quality embryos when using the PPOS protocol, switching to the modified ultra-long protocol after having 2 PPOS failures was associated with better ART outcomes. International Scientific Literature, Inc. 2020-01-18 /pmc/articles/PMC6986211/ /pubmed/31953378 http://dx.doi.org/10.12659/MSM.918705 Text en © Med Sci Monit, 2020 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Clinical Research Shen, Xi Gao, Hongyuan Chen, Qiuju Cai, Renfei Lyu, Qifeng Wang, Yun Wang, Li Kuang, Yanping Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures |
title | Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures |
title_full | Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures |
title_fullStr | Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures |
title_full_unstemmed | Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures |
title_short | Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures |
title_sort | effect of switching from a progestin-primed ovarian stimulation protocol to a modified ultra-long protocol among women who had 1 progestin-primed ovarian stimulation (ppos) failure verses those who had 2 ppos failures |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986211/ https://www.ncbi.nlm.nih.gov/pubmed/31953378 http://dx.doi.org/10.12659/MSM.918705 |
work_keys_str_mv | AT shenxi effectofswitchingfromaprogestinprimedovarianstimulationprotocoltoamodifiedultralongprotocolamongwomenwhohad1progestinprimedovarianstimulationpposfailureversesthosewhohad2pposfailures AT gaohongyuan effectofswitchingfromaprogestinprimedovarianstimulationprotocoltoamodifiedultralongprotocolamongwomenwhohad1progestinprimedovarianstimulationpposfailureversesthosewhohad2pposfailures AT chenqiuju effectofswitchingfromaprogestinprimedovarianstimulationprotocoltoamodifiedultralongprotocolamongwomenwhohad1progestinprimedovarianstimulationpposfailureversesthosewhohad2pposfailures AT cairenfei effectofswitchingfromaprogestinprimedovarianstimulationprotocoltoamodifiedultralongprotocolamongwomenwhohad1progestinprimedovarianstimulationpposfailureversesthosewhohad2pposfailures AT lyuqifeng effectofswitchingfromaprogestinprimedovarianstimulationprotocoltoamodifiedultralongprotocolamongwomenwhohad1progestinprimedovarianstimulationpposfailureversesthosewhohad2pposfailures AT wangyun effectofswitchingfromaprogestinprimedovarianstimulationprotocoltoamodifiedultralongprotocolamongwomenwhohad1progestinprimedovarianstimulationpposfailureversesthosewhohad2pposfailures AT wangli effectofswitchingfromaprogestinprimedovarianstimulationprotocoltoamodifiedultralongprotocolamongwomenwhohad1progestinprimedovarianstimulationpposfailureversesthosewhohad2pposfailures AT kuangyanping effectofswitchingfromaprogestinprimedovarianstimulationprotocoltoamodifiedultralongprotocolamongwomenwhohad1progestinprimedovarianstimulationpposfailureversesthosewhohad2pposfailures |